SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-017031
Filing Date
2023-05-10
Accepted
2023-05-10 08:07:58
Documents
14
Period of Report
2023-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aadi-20230510.htm   iXBRL 8-K 36919
2 EX-99.1 aadi-20230510xex991.htm EX-99.1 90367
6 aadilogo-pressrelease.jpg GRAPHIC 11355
  Complete submission text file 0001628280-23-017031.txt   288829

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aadi-20230510.xsd EX-101.SCH 1890
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aadi-20230510_lab.xml EX-101.LAB 24849
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aadi-20230510_pre.xml EX-101.PRE 13038
8 EXTRACTED XBRL INSTANCE DOCUMENT aadi-20230510_htm.xml XML 11851
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38560 | Film No.: 23904425
SIC: 2834 Pharmaceutical Preparations